Drug for cancer therapy

Details Drug for cancer therapy Drug for cancer therapy

A - Human Necessities

61

K

A61K 38/16 (2006.01) A23L 1/305 (2006.01) A61K 38/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) A61P 43/00 (2006.01) C07K 14/47 (2006.01)

Patent

CA 2533753

A lactoferrin partial peptide or lactoferrin hydrolyzate mixture that can be obtained by hydrolysis of lactoferrin with the use of a hydrolase and that in the antibody therapy for cancer, have the efficacy of enhancing the cytotoxic activity of antibody drug. The lactoferrin partial peptide or lactoferrin hydrolyzate mixture can be used as an active ingredient of medicine for enhancing the cytotoxic activity of antibody drug in the antibody therapy for cancer.

Peptide partiel de lactoferrine ou mélange d'hydrolysat de lactoferrine qu'on peut obtenir par hydrolyse de lactoferrine avec l'utilisation d'une hydrolase et qui, dans la thérapie par un anticorps pour un cancer, a l'efficacité pour augmenter l'activité cytotoxique d'un médicament à base d'anticorps. On peut utiliser le peptide partiel de lactoferrine ou le mélange d'hydrolysat de lactoferrine comme ingrédient actif d'un médicament servant à augmenter l'activité cytotoxique d'un médicament à base d'anticorps dans la thérapie par un anticorps pour un cancer.

Affiliated with

Also associated with

Rating

Drug for cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug for cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for cancer therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2065998